Inventiva (IVA) said late Wednesday it appointed Jason Campagna as chief medical officer and president of research and development.
Campagna succeeds Michael Cooreman, who is departing as chief medical officer. Co-founder and Chief Scientific Officer Pierre Broqua will transition to a consulting role as scientific advisor.
Campagna most recently was the chief medical officer at Q32 Bio (QTTB), Inventiva said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.